Maureen Gannon

Maureen Gannon, PhD, center, with Emilyn Alejandro, PhD, associate professor of Integrative Biology and Physiology at the University of Minnesota, left, and Maria Golson, PhD, assistant professor of Medicine at Johns Hopkins University, a former postdoctoral fellow of Gannon’s.
July 10, 2023

Gannon receives career achievement award for islet biology research

Vanderbilt’s Maureen Gannon, PhD, received the Paul Lacy Medal Award, the highest honor given by the Midwest Islet Club in recognition of meritorious career achievement in the field of islet biology.

By Jill Clendening
June 26, 2023

Irish step dancing and science share equal billing in Maureen Gannon’s world

She is known for her diabetes research. She’s also pretty proud of her polished lift, a high, straight-legged kick that shows both flexibility and gracefulness.

By Jill Clendening
A Vanderbilt study shows that reducing consumption of simple sugars helped improve gastroesophageal reflux disease.
June 13, 2023

Maternal diet influences postnatal diabetes risk

Studies in a primate animal model suggest that islet hyperfunction — which in humans is associated with increased fat mass and Type 2 diabetes — is programmed in offspring by a maternal Western-style diet during pregnancy.

By Bill Snyder
June 22, 2022

Gannon selected for American Diabetes Association Award

Maureen Gannon, PhD, professor of Medicine, Molecular Physiology and Biophysics, and Cell and Developmental Biology, is the recipient of the 2022 Lois Jovanovic Transformative Woman in Diabetes Award presented by the American Diabetes Association (ADA).

By Jill Clendening
May 24, 2022

Diabetes, cardiovascular drug targets

Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

By Leigh MacMillan
January 17, 2022

Inaugural members of the Vanderbilt Academy for Excellence in Clinical Medicine announced

The inaugural members of the Vanderbilt Academy for Excellence in Clinical Medicine (AECM) have been chosen.

By John Howser
October 28, 2021

Pancreatic beta-cell booster

Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications.
By Leigh MacMillan
August 15, 2019

Gannon named to new faculty development role

Maureen Gannon, PhD, has been named to the newly created role of Associate Dean for Faculty Development for Vanderbilt University School of Medicine.
By John Howser
September 13, 2018

First Islet Workshop draws international audience

More than 200 investigators from across the globe who specialize in islet biology, the study of hormone-producing cell clusters in the pancreas known as islets, recently gathered in Nashville to share knowledge and present the challenges and successes of their work during the first Islet Biology Workshop at Vanderbilt.
By Jill Clendening
May 3, 2017

Therapeutic targets for diabetes

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes.
By Leigh MacMillan
June 23, 2016

It takes two to tango: beta cell development

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes.
By Bill Snyder
May 5, 2016

Gannon to chair ADA science session planning committee

Maureen Gannon, Ph.D., associate professor of Medicine, has been appointed chair of the American Diabetes Association (ADA) Scientific Session planning committee.
By Bill Snyder
November 23, 2015

Ten Vanderbilt faculty members elected AAAS fellows

Ten members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science.
By Bill Snyder
1 2